Cann Group Funding: How Much Did They Raise & Key Investors

How Much Did Cann Group Raise?
Funding & Key Investors

Cann Group has solidified its standing as a cornerstone of the Australian medicinal cannabis industry, securing a significant capital infusion to bolster its operational capacity. With a total funding accumulation of $517K, the firm continues to leverage its unique regulatory status to scale production. The most recent strategic investment of $517K underscores the confidence institutional partners place in the company's long-term commercialization roadmap and its ability to navigate complex pharmaceutical supply chains.

This latest financing round serves as a critical milestone, enabling the organization to transition from research-heavy development into a fully integrated, high-output manufacturing entity. By securing this backing, Cann Group is well-positioned to accelerate its clinical evaluation programs and expand its footprint in the global therapeutic market.

What is Cann Group?

Cann Group

Manufacturing

Pharmaceuticals

Agriculture

Established in 2014, Cann Group holds the distinction of being the first entity granted a Cannabis Research Licence and Medicinal Cannabis Licence by the Australian Government's Office of Drug Control. The company operates at the intersection of advanced agronomy and pharmaceutical science, focusing on the cultivation, production, and manufacturing of medicinal cannabis products. Its business model is built upon a foundation of proprietary plant genetics and a vertically integrated supply chain that spans from initial breeding to final clinical distribution. By maintaining rigorous R&D standards and leveraging deep expertise in agricultural technology, Cann Group aims to address unmet medical needs through standardized, high-quality cannabis-based therapies.

How much funding has Cann Group raised?

Cann Group has raised a total of $517K across 1 funding round:

2022

Debt

$517K

Debt (2022): $517K with participation from National Australia Bank

Key Investors in Cann Group

National Australia Bank

National Australia Bank is a major international financial services institution providing comprehensive banking, credit, and investment solutions to corporate and institutional clients.

What's next for Cann Group?

Looking ahead, the strategic deployment of this capital will likely focus on optimizing cultivation yields and scaling manufacturing throughput to meet rising domestic and international demand. As the regulatory landscape for medicinal cannabis continues to evolve, Cann Group is poised to capitalize on its early-mover advantage by deepening its clinical research partnerships and expanding its portfolio of therapeutic products. The company's focus remains on achieving operational excellence and maintaining its leadership in the sector through sustained investment in plant science and commercial infrastructure. Keywords: medicinal cannabis, biotech investment, pharmaceutical manufacturing, plant genetics, Australian healthcare, clinical research, agricultural technology, enterprise funding.

See full Cann Group company page

See More Financial Insights

No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Apple King

Food & Beverage

Manufacturing

North Davis Cabinet

Furniture

Manufacturing

Miach Orthopaedics

Manufacturing

Medical Devices & Equipment

Aqua Systems

Manufacturing

Tires & Rubber

Cleaning Products

Chemicals & Related Products

Frequently Asked Questions Regarding Cann Group Financial Insights

What are the most recent funding rounds that Cann Group has completed, and what were the funding rounds?

Cann Group has recently completed 1 funding rounds: Debt on Jul 21, 2022.

What is the total amount of funding Cann Group has raised to date?

Cann Group has raised a total of $517K in funding to date.

How many funding rounds has Cann Group completed?

Cann Group has completed 1 funding rounds.

How much funding did Cann Group raise in its most recent funding round?

Cann Group raised $517K in its most recent funding round.

Who are the lead investors in Cann Group's latest funding round?

The lead investor in Cann Group's latest funding round was National Australia Bank. To access investor data and explore similar companies, sign up for ZoomInfo.

Which was the largest funding round in Cann Group's history?

The largest funding round in Cann Group's history was $517K.

See more information about Cann Group